'

Introducing Clinical Correlation, a new podcast drop from Psychcast!

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anxiety, Depression Compromise Believability of Drug-Allergy Testing

Publish date:: March 8, 2019

Key clinical point: Patients with anxiety or depression were more likely to doubt a negative drug-allergy test result.

Major finding: Skepticism about a negative drug-allergy result came from 24% of people with anxiety, 20% with depression, and 7% with neither.

Study details: A prospective study of 100 people at the drug-allergy clinic of one U.S. center.

Disclosures: Dr. Rukasin had no relevant financial disclosures.

Citation:

Rukasin C et al. J Allergy Clin Immunol. 2019 Feb;143(2):AB428.

This Week's Must Reads

Association of ketamine dose and blood levels with antidepressant response,

Can ECT be extended to patients with moderate-severity MDD?,

Treatment-resistant depression raises risk of dementia and Alzheimer's disease,

No increased risk of suicide with pimavanserin in patients with MDD,

Esketamine nasal spray rapidly reduces depressive symptoms in MDD patients with suicidal ideation and intent,

Must Reads in Anxiety Disorders

Mental health risks rise with age and stage for gender-incongruent youth,

Teen affective disorders raise risk for midlife acute MI,

Divergent COVID-19 mental health impacts seen in Spain and China,

Atopic dermatitis in adults, children linked to neuropsychiatric disorders,

CBT by phone reduces depression in Parkinson’s disease,